Literature DB >> 16542253

Random change point model for joint modeling of cognitive decline and dementia.

Hélène Jacqmin-Gadda1, Daniel Commenges, Jean-François Dartigues.   

Abstract

We propose a joint model for cognitive decline and risk of dementia to describe the pre-diagnosis phase of dementia. We aim to estimate the time when the cognitive evolution of subjects in the pre-dementia phase becomes distinguishable from normal evolution and to study whether the shape of cognitive decline depends on educational level. The model combines a piecewise polynomial mixed model with a random change point for the evolution of the cognitive test and a log-normal model depending on the random change point for the time to dementia. Parameters are estimated by maximum likelihood using a Newton-Raphson-like algorithm. The expected cognitive evolution given age to dementia is then derived and the marginal distribution of dementia is estimated to check the log-normal assumption.

Entities:  

Mesh:

Year:  2006        PMID: 16542253      PMCID: PMC2233714          DOI: 10.1111/j.1541-0420.2005.00443.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  16 in total

1.  Survival analysis using auxiliary variables via multiple imputation, with application to AIDS clinical trial data.

Authors:  Cheryl L Faucett; Nathaniel Schenker; Jeremy M G Taylor
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure.

Authors:  Ngayee J Law; Jeremy M G Taylor; Howard Sandler
Journal:  Biostatistics       Date:  2002-12       Impact factor: 5.899

3.  A latent process model for joint modeling of events and marker.

Authors:  R Hashemi; H Jacqmin-Gadda; D Commenges
Journal:  Lifetime Data Anal       Date:  2003-12       Impact factor: 1.588

4.  Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcomes.

Authors:  Donna K Pauler; Dianne M Finkelstein
Journal:  Stat Med       Date:  2002-12-30       Impact factor: 2.373

5.  A penalized likelihood approach for arbitrarily censored and truncated data: application to age-specific incidence of dementia.

Authors:  P Joly; D Commenges; L Letenneur
Journal:  Biometrics       Date:  1998-03       Impact factor: 2.571

6.  A joint model for survival and longitudinal data measured with error.

Authors:  M S Wulfsohn; A A Tsiatis
Journal:  Biometrics       Date:  1997-03       Impact factor: 2.571

7.  Modelling progression of CD4-lymphocyte count and its relationship to survival time.

Authors:  V De Gruttola; X M Tu
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

8.  Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons.

Authors:  D M Masur; M Sliwinski; R B Lipton; A D Blau; H A Crystal
Journal:  Neurology       Date:  1994-08       Impact factor: 9.910

9.  A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease.

Authors:  C B Hall; R B Lipton; M Sliwinski; W F Stewart
Journal:  Stat Med       Date:  2000 Jun 15-30       Impact factor: 2.373

10.  A penalized likelihood approach for an illness-death model with interval-censored data: application to age-specific incidence of dementia.

Authors:  Pierre Joly; Daniel Commenges; Catherine Helmer; Luc Letenneur
Journal:  Biostatistics       Date:  2002-09       Impact factor: 5.899

View more
  25 in total

1.  Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer's Disease.

Authors:  S Duke Han; Jonathan Gruhl; Laurel Beckett; Hiroko H Dodge; Nikki H Stricker; Sarah Farias; Dan Mungas
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

2.  A latent process model for dementia and psychometric tests.

Authors:  Julien Ganiayre; Daniel Commenges; Luc Letenneur
Journal:  Lifetime Data Anal       Date:  2008-06       Impact factor: 1.588

3.  When does cognitive decline begin? A systematic review of change point studies on accelerated decline in cognitive and neurological outcomes preceding mild cognitive impairment, dementia, and death.

Authors:  Justin E Karr; Raquel B Graham; Scott M Hofer; Graciela Muniz-Terrera
Journal:  Psychol Aging       Date:  2018-03

4.  An evaluation of analytical approaches for understanding change in cognition in the context of aging and health.

Authors:  Andrea M Piccinin; Graciela Muniz; Catharine Sparks; Daniel E Bontempo
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2011-07       Impact factor: 4.077

5.  Quantile regression with a change-point model for longitudinal data: An application to the study of cognitive changes in preclinical alzheimer's disease.

Authors:  Chenxi Li; N Maritza Dowling; Rick Chappell
Journal:  Biometrics       Date:  2015-04-17       Impact factor: 2.571

6.  Intensive Measurement Designs for Research on Aging.

Authors:  Philippe Rast; Stuart W S Macdonald; Scott M Hofer
Journal:  GeroPsych (Bern)       Date:  2012

7.  Approximate nonparametric corrected-score method for joint modeling of survival and longitudinal data measured with error.

Authors:  Jean D Tapsoba; Jean de Dieu Tapsoba; Shen-Ming Lee; C Y Wang
Journal:  Biom J       Date:  2011-07       Impact factor: 2.207

8.  Bivariate random change point models for longitudinal outcomes.

Authors:  Lili Yang; Sujuan Gao
Journal:  Stat Med       Date:  2012-08-15       Impact factor: 2.373

9.  Depressive, functional status, and neuropsychiatric symptom trajectories before an Alzheimer's disease diagnosis.

Authors:  Joseph E Gaugler; Martha Hovater; David L Roth; Joseph A Johnston; Robert L Kane; Khaled Sarsour
Journal:  Aging Ment Health       Date:  2013-07-04       Impact factor: 3.658

10.  A random change point model for assessing variability in repeated measures of cognitive function.

Authors:  Annica Dominicus; Samuli Ripatti; Nancy L Pedersen; Juni Palmgren
Journal:  Stat Med       Date:  2008-11-29       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.